COURSE DIRECTORS
Susan Cullinan, M.D.; Carl Gladitsch, M.D.; David Cullen, P.A.-C

DESCRIPTION
Regional based case review of identified M&M cases or self presented interesting cases.  There is an overview of the case as well as identifying areas of improvements as well as educational pearls.  Sessions are held on the 4th Thursday.

TARGET AUDIENCE
This course is intended primarily for Emergency Medicine, Physicians and NP/PAs.

LEARNING OBJECTIVES
Upon conclusion of this activity, participants should be able to:

• Utilize the most appropriate labs and radiologic studies for our emergency medicine population.  
• Identify “red flags” in common presenting conditions that merit further workup. 
• Identify variability in practice for workup and treatment of emergent conditions.  
• Identify “systems issues” that lead to morbidity or inefficiency in ED care.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Summary
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevent financial relationship(s) with ineligible companies: 
None 

All relevant financial relationships listed for these individuals have been mitigated.